Chronic Fatigue Syndrome (CFS) is a prevalent condition that often manifests in the body following a viral infection, believed to persist as a chronic continuation of the initial viral illness. Through years of managing viral diseases, our clinical expertise extends to both the acute and chronic phases of their progression. However, the clinical manifestation during the chronic phase can sometimes surpass the acute phase in severity, attributed to significant depletion of the immune system during the initial acute process. Consequently, the virus remains active, continuing to inflict harm on the patient’s body.

Our clinical investigations, particularly with viral infections like herpes zoster, corroborate this phenomenon. Here, we note clinical symptoms and biochemical findings that correlate, notably observing higher viral titers in the chronic phase compared to the acute stage. Yet, the myriad of viruses existing around us, often undetectable without laboratory analysis, complicates our diagnostic approach, underscoring the elusive nature of Chronic Fatigue Syndrome’s causative agents.

Symptoms of CFS encompass profound weakness, headaches, dizziness, disrupted sleep, anxiety, leg heaviness, as well as muscle and joint pain, akin to the acute phase of a typical flu. This condition can persist from months to years, significantly impacting the patient’s quality of life and potentially predisposing them to serious complications, including malignancies.

Treatment modalities such as intravenous ozone therapy and TEN-pass or multipass treatments offer avenues to combat viral persistence. Nonetheless, in refractory cases, adjunctive measures employing specialized equipment to stimulate lymphatic flow prove indispensable in managing chronic viral processes effectively.

Addressing chronic viral infections mandates adherence to precise treatment protocols alongside access to advanced equipment and specialized medications. At our medical center, equipped with comprehensive resources and leveraging our extensive experience and favorable outcomes, we stand committed to effectively addressing this challenge.

Treatment for each patient culminates upon obtaining negative DNA test results, with stress tests conducted at the onset and conclusion of treatment to evaluate the patient’s physiological status. Guided by initial assessments, we tailor a rehabilitation program tailored to individual patients, with subsequent tests reflecting treatment progress. In severe cases of Chronic Fatigue Syndrome, repeated rehabilitation courses may be warranted, possibly on an annual basis.

Upon treatment completion, patients receive comprehensive recommendations and ongoing support throughout their recovery journey.

Wishing you health and vitality.